(Press-News.org) In a potential breakthrough against ovarian cancer, University of Guelph researchers have discovered how to both shrink tumours and improve drug delivery, allowing for lower doses of chemotherapy and reducing side effects.
Their research appears today in the FASEB Journal, one of the world's top biology publications.
"We hope that this study will lead to novel treatment approaches for women diagnosed with late-stage ovarian cancer," said Jim Petrik, a Guelph biomedical sciences professor. He worked on the study with Guelph graduate student Samantha Russell and cancer researchers from Harvard Medical School. Petrik is scheduled to present the paper Friday at Harvard's Translational Cancer Program.
"The development of new therapies to treat women with advanced ovarian cancer is essential in order to reduce the morbidity and mortality associated with this disease."
Ovarian cancer is the most lethal gynecological cancer; about 150,000 women worldwide die each year of the disease. Women can have the disease for years without knowing it because the symptoms, which include nausea, bloating and abdominal pain, are vague and attributable to many ailments.
In about eight out of 10 cases, ovarian cancer is detected only at an advanced stage, and the odds of survival are poor. "This is why it's known as the 'silent killer,'" Petrik said.
Women often succumb to ovarian cancer because the inefficient delivery of chemotherapy drugs allows the cells to build up resistance so they no longer respond to treatment, he said.
"The five-year survival rate for ovarian cancer has changed very little over the last 20 years, and new treatment options are urgently needed."
Petrik, who has researched ovarian cancer for nearly 15 years, focuses on anti-angiogenic therapies.
Ovarian tumours, like many other types of cancer, obtain nutrients and oxygen by inducing growth of new blood vessels, a process termed "angiogenesis."
His recent study focuses on a portion of a naturally occurring protein inhibitor molecule called 3TSR. It interacts with another protein found on the surface of endothelial cells, reducing abnormal tumor angiogenesis.
"We also made the surprising discovery that 3TSR causes ovarian cancer cells to die through a direct inhibitory effect against the tumour itself," Petrik said.
Giving 3TSR to patients with advanced-stage ovarian cancer would help patients in two ways, Petrik said. "With this novel approach, we were able to both shrink the tumor and enhance the ability of the tumor to take up chemotherapy drugs."
More efficient drug delivery also means doctors can administer lower amounts of chemotherapy, alleviating many of the side effects, he said.
"One of the main problems with current treatment regimens is the significant side effects caused by the high doses of chemotherapy that women with ovarian cancer receive."
He used an animal model of advanced-stage ovarian cancer -- the same stage when most women are diagnosed with ovarian cancer. "It makes our studies very relevant to the current clinical scenario," Petrik said.
He and his collaborators are working towards human trials and, ultimately, to the development of targeted cancer therapies.
While the study focused on ovarian cancer, the approach could help in treating other solid tumours, Petrik said.
INFORMATION:
LAWRENCE -- Like hedonistic rock stars that live by the "better to burn out than to fade away" credo, certain galaxies flame out in a blaze of glory. Astronomers have struggled to grasp why these young "starburst" galaxies -- ones that are very rapidly forming new stars from cold molecular hydrogen gas up to 100 times faster than our own Milky Way -- would shut down their prodigious star formation to join a category scientists call "red and dead."
Starburst galaxies typically result from the merger or close encounter of two separate galaxies. Previous research had revealed ...
INDIANAPOLIS -- Researchers have identified two proteins that appear crucial to the development -- and patient relapse -- of acute myeloid leukemia. They have also shown they can block the development of leukemia by targeting those proteins.
The studies, in animal models, could lead to new effective treatments for leukemias that are resistant to chemotherapy, said Reuben Kapur, Ph.D., Freida and Albrecht Kipp Professor of Pediatrics at the Indiana University School of Medicine.
The research was reported today in the journal Cell Reports.
"The issue in the field for ...
Plants all over the world are more sensitive to drought than many experts realized, according to a new study by scientists at UCLA and China's Xishuangbanna Tropical Botanical Garden. The research will improve predictions of which plant species will survive the increasingly intense droughts associated with global climate change.
The research is reported online by Ecology Letters, the most prestigious journal in the field of ecology, and will be published in an upcoming print edition.
Predicting how plants will respond to climate change is crucial for their conservation. ...
MOUNT VERNON, Wash. -- A new study by researchers at Washington State University shows that mechanical harvesting of cider apples can provide labor and cost savings without affecting fruit, juice, or cider quality.
The study, published in the journal HortTechnology in October, is one of several studies focused on cider apple production in Washington State. It was conducted in response to growing demand for hard cider apples in the state and the nation.
Quenching a thirst for cider
Hard cider consumption is trending steeply upward in the region surrounding the food-conscious ...
As our society ages, a University of Montreal study suggests the health system should be focussing on comorbidity and specific types of disabilities that are associated with higher health care costs for seniors, especially cognitive disabilities. Comorbidity is defined as the presence of multiple disabilities. Michaël Boissonneault and Jacques Légaré of the university's Department of Demography came to this conclusion after assessing how individual factors are associated with variation in the public costs of healthcare by studying disabled Quebecers over ...
The scientists showed that the Parkin protein functions to repair or destroy damaged nerve cells, depending on the degree to which they are damaged
People living with Parkinson's disease often have a mutated form of the Parkin gene, which may explain why damaged, dysfunctional nerve cells accumulate
Dublin, Ireland, November 13th, 2014 - Scientists at Trinity College Dublin have made an important breakthrough in our understanding of Parkin - a protein that regulates the repair and replacement of nerve cells within the brain. This breakthrough generates a new perspective ...
There are no approved treatments or preventatives against Ebola virus disease, but investigators have now designed peptides that mimic the virus' N-trimer, a highly conserved region of a protein that's used to gain entry inside cells.
The team showed that the peptides can be used as targets to help researchers develop drugs that might block Ebola virus from entering into cells.
"In contrast to the most promising current approaches for Ebola treatment or prevention, which are species-specific, our 'universal' target will enable the selection of broad-spectrum inhibitors ...
In a study of middle-aged men who were overweight, researchers found that if a man's parents were older at the time of his birth, he was more likely to have lower blood pressure, more favorable cholesterol levels, and improved glucose metabolism. It's unknown whether the beneficial effect was due to having an older mother, an older father, or both.
Additional studies are necessary to help shed light on the effects of parental age at childbirth on the metabolism of men and women. "In particular, more research is required to understand whether these effects are due to ...
In a study that looked at what factors might affect whether or not a patient receives intensive medical procedures in the last 6 months of life, investigators found that older age, Alzheimer's disease, cancer, living in a nursing home, and having an advance directive were associated with a lower likelihood of undergoing an intensive procedure. In contrast, living in a region with higher hospital care intensity and black race each doubled a patient's likelihood of undergoing an intensive procedure.
"It's pretty striking the extent to which nonclinical factors--such as ...
Preeclampsia, a late-pregnancy disorder that is characterized by high blood pressure and organ damage, may be caused by problems related to meeting the oxygen demands of the growing fetus, experts say in a new Anaesthesia paper.
Left untreated, preeclampsia can lead to serious--even fatal--complications for a pregnant woman and her baby. The new theory challenges the current view that pre-eclampsia is caused by a problem with the placenta. "When the fetus is not getting enough oxygen and nutrients for its growth--due to conditions in the mother, conditions in the placenta ...
